Literature DB >> 8425688

Ileal proglucagon gene expression in the rat: characterization in intestinal adaptation using in situ hybridization.

P J Fuller1, D J Beveridge, R G Taylor.   

Abstract

BACKGROUND: Proglucagon-derived peptides are potential mediators of the adaptive response of the terminal ileum to massive small bowel resection. Ileal proglucagon messenger RNA (mRNA) levels increase during ileal adaptation. The present study explored the cellular basis of this response.
METHODS: Sections of control ileum, ileum 4 days after resection, and pancreas were analyzed by in situ hybridization with 35S-labeled complementary RNA (cRNA) probes.
RESULTS: Both the proglucagon and the peptide YY cRNA probes hybridized to discrete cells in the ileal mucosa, the disposition of which corresponds to that reported for intestinal L cells. Four days after resection there was a marked increase in the intensity of the signal for both probes without an increase in cell number. Insulin and histone H3 probes were used as controls to confirm the specificity of the hybridization seen with the L-cell specific, proglucagon, and peptide YY probes.
CONCLUSIONS: The increase in proglucagon mRNA levels after massive small bowel resection is caused by an increase in the cellular content. The parallel increase in PYY mRNA levels implies an L cell--rather than a proglucagon gene--specific response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425688     DOI: 10.1016/0016-5085(93)90414-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  Gut adaptation and the glucagon-like peptides.

Authors:  D J Drucker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  Trophic response of gut and pancreas after ileojejunal transposition.

Authors:  K U Chu; T Tsuchiya; J Ishizuka; T Uchida; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

3.  Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

Authors:  D J Drucker; P Erlich; S L Asa; P L Brubaker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro.

Authors:  Jasleen Jasleen; Stanley W Ashley; Naoshi Shimoda; Michael J Zinner; Edward E Whang
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

Review 5.  The management of patients with the short bowel syndrome.

Authors:  Cameron F E Platell; Jane Coster; Rosalie D McCauley; John C Hall
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Gene expression in the adapting small bowel after massive small bowel resection.

Authors:  Lyrissa Baksheev; Peter J Fuller
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

7.  Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre.

Authors:  J Thulesen; B Hartmann; C Nielsen; J J Holst; S S Poulsen
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

8.  Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection.

Authors:  J Thulesen; B Hartmann; H Kissow; P B Jeppesen; C Orskov; J J Holst; S S Poulsen
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

9.  Purification and sequence of rat oxyntomodulin.

Authors:  N L Collie; J H Walsh; H C Wong; J E Shively; M T Davis; T D Lee; J R Reeve
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.